07.08.2013 • NewsQ2 2013BrenntagQ2 results

Brenntag Reports Positive Q2

Brenntag has reported sales up in Q2, increasing 3.4% and reaching €2,544.7 million. The Germany-based chemical distributor's gross profit also grew 4.6% year-over-year to €502 million. External sales in Europe increased by 1.2% to €1,184 million over 2012 numbers, despite an uncertain economic situation here. In North America, Brenntag attributes its growth there to the 2012 acquisition of the Altivia Cooperation; sales were up 6.5% at €817.2 million. The company also saw positive development in the Asia Pacific region following the acquisition of the ISM/Salkat Group; here, sales were up 9.6% to €186.9 million. Operating gross profit was up 21.4% at €31.1. The group's operating gross profit increased in Latin America by 4.6% to €43.4 million; however, external sales were down 2.2% at €221.4 million.   

For the rest of the year, the company said it is "anticipating less dynamic development." Taking the uncertain macroeconomic situation into consideration, Brenntag said it expects the groups operating EBITDA to fall between €710-735 million.  

"We do not see the promise of any significant improvement in the macroeconomic environment but we remain positive and confident about the underlying market opportunities and resilience of our business leading to further growth of the group overall," Brenntag CEO Steven Holland said.  

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.